Table 5 of Engin, Mol Vis 2010; 16:1260-1271.
Table 5. Statistical significance of serum oxidative stress markers based on clinical parameters.
| Parameters | Groups | TADA | AOPP | SOD | Gpx | MDA | Ser | TF | Vit A | Vit E |
|---|---|---|---|---|---|---|---|---|---|---|
| Gender | Female | ** | ** | *** | ||||||
| Male | ** | ** | * | *** | ||||||
| Age (years) | <40 | * | *** | * | * | *** | ||||
| 40–60 | *** | *** | * | *** | ||||||
| >60 | * | * | *** | |||||||
| Visual acuity | N | * | *** | * | * | *** | ||||
| D | * | * | * | |||||||
| IOP | N | *** | * | * | * | * | *** | |||
| U | * | *** | *** | |||||||
| B | * | *** | * | *** | ||||||
| c/d | N | *** | * | *** | *** | * | * | |||
| U | ** | * | ** | |||||||
| B | * | *** | * | *** | ||||||
| Angle | Wide | *** | * | *** | * | *** | ||||
| Narrow | * | *** | * | *** | ||||||
| Drugs | (-) | * | * | *** | * | *** | ||||
| PG | * | * | * | ** | ||||||
| β-b | * | ** | ** | |||||||
| 2 drugs | ||||||||||
| 3 drugs | ||||||||||
| Px | (+) | * | *** | ** | ||||||
| (-) | * | ** | * |